Discussing recent FDA approvals for expanded indications for trastuzumab-deruxtecan for gastric cancer (based on DESTINY-Gastric01) and SC daratumumab for AL amyloidosis.

DESTINY-Gastric01: https://www.nejm.org/doi/full/10.1056/NEJMoa2004413

Discussing recent FDA approvals for expanded indications for trastuzumab-deruxtecan for gastric cancer (based on DESTINY-Gastric01) and SC daratumumab for AL amyloidosis. DESTINY-Gastric01: https://www.nejm.org/doi/full/10.1056/NEJMoa2004413

Updates T-DXd (gastric) & SC Dara (AL Amyloidosis)

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Science

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Share Updates T-DXd (gastric) & SC Dara (AL Amyloidosis)

Sign up to save your podcasts

Updates T-DXd (gastric) & SC Dara (AL Amyloidosis)

Updates T-DXd (gastric) & SC Dara (AL Amyloidosis)

More shows like OncoPharm

JAMA Clinical Reviews

ASCO Daily News

White Coat Investor Podcast

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The ONS Podcast

ASCO Guidelines

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

OncLive® On Air

Oncology Today with Dr Neil Love

The Curious Clinicians

Ninja Nerd

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

WolverHeme Happy Hour